10-Q 1 d324285d10q.htm 10-Q 10-Q
10001830232--12-31falseQ1CA 0001830232 2022-03-31 0001830232 2021-12-31 0001830232 2022-01-01 2022-03-31 0001830232 2021-01-01 2021-03-31 0001830232 2022-05-31 0001830232 2021-01-11 0001830232 2021-01-01 2021-12-31 0001830232 2020-12-31 0001830232 2021-03-31 0001830232 srt:MaximumMember 2022-03-31 0001830232 us-gaap:CommonClassAMember 2022-03-31 0001830232 agcb:PublicSharesMember 2022-03-31 0001830232 agcb:WorkingCapitalLoansThatMayBeConvertibleIntoWarrantsMember agcb:SponsorOrAffiliateOfSponsorOrCertainOfOfficersAndDirectorsMember 2022-03-31 0001830232 us-gaap:CommonClassBMember 2022-03-31 0001830232 us-gaap:CommonClassBMember agcb:FounderSharesMember 2022-03-31 0001830232 us-gaap:CommonClassBMember us-gaap:InvestorMember agcb:FounderSharesMember 2022-03-31 0001830232 srt:MaximumMember us-gaap:CommonClassBMember us-gaap:InvestorMember agcb:FounderSharesMember 2022-03-31 0001830232 srt:MinimumMember us-gaap:InvestorMember us-gaap:CommonClassAMember agcb:FounderSharesMember 2022-03-31 0001830232 agcb:UsTreasurySecuritiesMoneyMarketFundMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001830232 us-gaap:MoneyMarketFundsMember us-gaap:USTreasurySecuritiesMember 2022-03-31 0001830232 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-03-31 0001830232 us-gaap:MeasurementInputExpectedTermMember 2022-03-31 0001830232 agcb:MeasurementInputPriceProbabilityMember 2022-03-31 0001830232 us-gaap:MeasurementInputSharePriceMember 2022-03-31 0001830232 agcb:ClassARedeemableCommonStockMember 2022-03-31 0001830232 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2022-03-31 0001830232 agcb:SponsorOrAffiliateOfSponsorOrCertainOfOfficersAndDirectorsMember 2022-03-31 0001830232 srt:MinimumMember 2022-03-31 0001830232 srt:MinimumMember agcb:DefinitiveAgreementOfBusinessCombinationMember 2022-03-31 0001830232 us-gaap:CommonClassAMember 2021-12-31 0001830232 us-gaap:CommonClassBMember 2021-12-31 0001830232 agcb:WorkingCapitalLoansThatMayBeConvertibleIntoWarrantsMember agcb:SponsorOrAffiliateOfSponsorOrCertainOfOfficersAndDirectorsMember 2021-12-31 0001830232 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member agcb:UsTreasurySecuritiesMoneyMarketFundMember 2021-12-31 0001830232 us-gaap:USTreasurySecuritiesMember us-gaap:MoneyMarketFundsMember 2021-12-31 0001830232 us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001830232 us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001830232 agcb:MeasurementInputPriceProbabilityMember 2021-12-31 0001830232 us-gaap:MeasurementInputSharePriceMember 2021-12-31 0001830232 agcb:ClassARedeemableCommonStockMember 2021-12-31 0001830232 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001830232 agcb:SponsorOrAffiliateOfSponsorOrCertainOfOfficersAndDirectorsMember agcb:WorkingCapitalLoansThatMayBeConvertibleIntoWarrantsMember 2022-01-01 2022-03-31 0001830232 agcb:AccruedExpenseMember 2022-01-01 2022-03-31 0001830232 us-gaap:InvestorMember agcb:MonthlyFeeForOfficeSpaceUtilitiesAndSecretarialAndAdministrativeSupportMember 2022-01-01 2022-03-31 0001830232 us-gaap:OverAllotmentOptionMember 2022-01-01 2022-03-31 0001830232 us-gaap:IPOMember 2022-01-01 2022-03-31 0001830232 us-gaap:PrivatePlacementMember 2022-01-01 2022-03-31 0001830232 agcb:SponsorAndSponsorsAffiliatesMember srt:MinimumMember us-gaap:PrivatePlacementMember 2022-01-01 2022-03-31 0001830232 us-gaap:CommonClassAMember 2022-01-01 2022-03-31 0001830232 us-gaap:CommonClassBMember 2022-01-01 2022-03-31 0001830232 agcb:ClassARedeemableCommonStockMember 2022-01-01 2022-03-31 0001830232 agcb:ClassAAndClassBNonredeemableCommonStockMember 2022-01-01 2022-03-31 0001830232 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001830232 us-gaap:FairValueInputsLevel3Member agcb:FpaLiabilityMember 2022-01-01 2022-03-31 0001830232 srt:MinimumMember 2022-01-01 2022-03-31 0001830232 srt:MaximumMember 2022-01-01 2022-03-31 0001830232 us-gaap:InvestorMember agcb:MonthlyFeeForOfficeSpaceUtilitiesAndSecretarialAndAdministrativeSupportMember 2021-01-01 2021-03-31 0001830232 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001830232 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001830232 agcb:ClassARedeemableCommonStockMember 2021-01-01 2021-03-31 0001830232 agcb:ClassAAndClassBNonredeemableCommonStockMember 2021-01-01 2021-03-31 0001830232 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001830232 agcb:PrivatePlacementWarrantMember 2021-01-01 2021-03-31 0001830232 us-gaap:CommonClassBMember 2021-01-01 2021-03-31 0001830232 us-gaap:CommonClassAMember 2021-01-01 2021-03-31 0001830232 us-gaap:PrivatePlacementMember 2021-01-11 2021-01-11 0001830232 us-gaap:OverAllotmentOptionMember agcb:PublicSharesMember 2021-01-11 2021-01-11 0001830232 agcb:PublicSharesMember us-gaap:IPOMember 2021-01-11 2021-01-11 0001830232 agcb:MonthlyFeeForOfficeSpaceUtilitiesAndSecretarialAndAdministrativeSupportMember us-gaap:InvestorMember 2021-01-11 2021-01-11 0001830232 agcb:SponsorOrAffiliateOfSponsorOrCertainOfOfficersAndDirectorsMember 2021-01-11 0001830232 agcb:PublicSharesMember us-gaap:IPOMember 2021-01-11 0001830232 us-gaap:PrivatePlacementMember 2021-01-11 0001830232 agcb:PublicSharesMember us-gaap:OverAllotmentOptionMember 2021-01-11 0001830232 srt:MaximumMember 2021-01-11 0001830232 agcb:FounderSharesMember us-gaap:CommonClassBMember us-gaap:InvestorMember 2020-10-23 2020-10-23 0001830232 us-gaap:InvestorMember agcb:PromissoryNoteToCoverExpensesRelatedToInitialPublicOfferingMember 2020-10-23 2020-10-23 0001830232 us-gaap:InvestorMember us-gaap:CommonClassAMember agcb:FounderSharesMember 2020-10-23 2020-10-23 0001830232 srt:MinimumMember us-gaap:InvestorMember us-gaap:CommonClassAMember agcb:FounderSharesMember 2020-10-23 2020-10-23 0001830232 us-gaap:InvestorMember agcb:PromissoryNoteToCoverExpensesRelatedToInitialPublicOfferingMember 2021-01-15 2021-01-15 0001830232 us-gaap:PrivatePlacementMember 2022-05-31 0001830232 agcb:FounderSharesMember agcb:DirectorOneMember us-gaap:CommonClassBMember 2020-12-01 2020-12-31 0001830232 us-gaap:CommonClassBMember agcb:DirectorTwoMember agcb:FounderSharesMember 2020-12-01 2020-12-31 0001830232 agcb:DirectorThreeMember us-gaap:CommonClassBMember agcb:FounderSharesMember 2020-12-01 2020-12-31 0001830232 us-gaap:CommonClassBMember agcb:DirectorFourMember agcb:FounderSharesMember 2020-12-01 2020-12-31 0001830232 us-gaap:CommonClassBMember srt:DirectorMember agcb:FounderSharesMember 2020-12-01 2020-12-31 0001830232 us-gaap:CommonClassBMember agcb:FounderSharesMember 2020-12-01 2020-12-31 0001830232 us-gaap:CommonClassBMember agcb:FounderSharesMember 2020-12-24 2020-12-24 0001830232 us-gaap:CommonClassBMember agcb:FounderSharesMember 2021-01-07 2021-01-07 0001830232 us-gaap:CommonClassBMember us-gaap:InvestorMember agcb:FounderSharesMember 2020-10-23 0001830232 agcb:AccruedExpenseMember 2022-01-01 2022-12-31 0001830232 us-gaap:FairValueInputsLevel3Member agcb:FpaLiabilityMember 2021-01-11 2021-03-31 0001830232 us-gaap:CommonClassBMember 2022-05-16 0001830232 us-gaap:CommonClassAMember 2022-05-16 0001830232 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-12-31 0001830232 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2021-12-31 0001830232 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001830232 us-gaap:RetainedEarningsMember 2021-12-31 0001830232 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2022-03-31 0001830232 us-gaap:RetainedEarningsMember 2022-03-31 0001830232 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001830232 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2022-03-31 0001830232 us-gaap:FairValueInputsLevel3Member agcb:FpaAssetMember 2021-12-31 0001830232 us-gaap:FairValueInputsLevel3Member agcb:FpaAssetMember 2022-03-31 0001830232 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2020-12-31 0001830232 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2020-12-31 0001830232 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001830232 us-gaap:RetainedEarningsMember 2020-12-31 0001830232 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2021-03-31 0001830232 us-gaap:RetainedEarningsMember 2021-03-31 0001830232 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001830232 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001830232 us-gaap:FairValueInputsLevel3Member agcb:FpaLiabilityMember 2021-01-10 0001830232 us-gaap:FairValueInputsLevel3Member agcb:FpaLiabilityMember 2021-03-31 iso4217:USD xbrli:shares xbrli:pure utr:Day utr:Month iso4217:USD xbrli:shares utr:Year utr:Y
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM
10-Q
 
 
(MARK ONE)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended March 31, 2022
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                    
to
                    
Commission file number: 001-39849
 
 
ALTIMETER GROWTH CORP. 2
(Exact Name of Registrant as Specified in Its Charter)
 
 
 
Cayman Islands
 
98-1563924
(State or other jurisdiction
of incorporation or organization)
 
(I.R.S. Employer
Identification No.)
   
2550 Sand Hill Road, Suite 150
   
Menlo Park, CA
 
94025
(Address of principal executive offices)
 
(Zip Code)
(650)
549-9145
(Issuer’s telephone number, including area code)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
 
Trading
Symbol(s)
 
Name of each exchange
on which registered
Class A ordinary shares
 
AGCB
 
New York Stock Exchange LLC
Check whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  ☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation
S-T
(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  ☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated
filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer”, “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule
12b-2
of the Exchange Act.
 
Large accelerated filer      Accelerated filer  
       
Non-accelerated filer      Smaller reporting company  
       
         Emerging growth company  
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Indicate by check mark whether the registrant is a shell company (as defined in Rule
12b-2
of the Exchange Act).     Yes   ☒     No   ☐
As of
May 16, 2022
, there were 46,100,000 Class A ordinary shares, $0.0001 par value and 11,250,000 Class B ordinary shares, $0.0001 par value, issued and outstanding.
 
 
 

ALTIMETER GROWTH CORP. 2
FORM
10-Q
FOR THE QUARTER ENDED
MARCH 31, 2022
TABLE OF CONTENTS
 
 
  
Page
 
  
  
  
 
1
 
  
 
2
 
  
 
3
 
  
 
4
 
  
 
5
 
  
 
16
 
  
 
19
 
  
 
19
 
  
 
21
 
  
 
21
 
  
 
21
 
  
 
21
 
  
 
21
 
  
 
21
 
  
 
21
 
  
 
22
 
  
 
23
 
 

PART I – FINANCIAL INFORMATION
 
ITEM 1.
FINANCIAL STATEMENTS
ALTIMETER GROWTH CORP. 2
CONDENSED BALANCE SHEETS
 
 
  
March 31, 2022
 
 
December 31, 2021
 
 
  
(Unaudited)
 
 
 
 
ASSETS
  
 
Current Assets
  
 
 
 
 
 
 
 
 
 
 
Cash
   $ 19,303     $ 398,681  
Prepaid Expenses
     300,093       405,223  
    
 
 
   
 
 
 
Total Current Assets
  
 
319,396
 
 
 
803,904
 
FPA Asset
     133,829       394,350  
Marketable securities held in Trust Account
     450,064,876       450,028,147  
    
 
 
   
 
 
 
TOTAL ASSETS
  
 
450,518,101
 
 
 
451,226,401
 
    
 
 
   
 
 
 
LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT
                
Current Liabilities
                
Accrued expenses and accounts payable
   $ 839,142     $ 814,452  
Accounts payable – related party
     46,219       46,219  
    
 
 
   
 
 
 
Total Current Liabilities
  
 
885,361
 
 
 
860,671
 
Deferred underwriting fee payable
     15,750,000       15,750,000  
    
 
 
   
 
 
 
Total Liabilities
  
 
16,635,361
 
 
 
16,610,671
 
Commitments and Contingencies (Note 6)
            
Class A ordinary shares subject to possible redemption, $0.0001 par value, 45,000,000 shares outstanding as of March 31, 2022 and December 31, 2021, respectively, at a redemption value of $10.00 per share
     450,000,000       450,000,000  
Shareholders’ Deficit
                
Preference Shares, $0.0001 par value; 1,000,000 shares authorized, no shares issued or outstanding
                  
Class A ordinary shares, $0.0001 par value, 200,000,000 shares authorized, 1,100,000 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively
 
(excluding 45,000,000 shares subject to redemption)
     110       110  
Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 11,250,000 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively
     1,125       1,125  
Additional
paid-in
capital
                  
Accumulated deficit
     (16,118,495     (15,385,505
    
 
 
   
 
 
 
Total Shareholders’ Deficit
  
 
(16,117,260
 
 
(15,384,270
    
 
 
   
 
 
 
TOTAL LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEF
I
CIT
  
$
450,518,101
 
 
$
451,226,401
 
    
 
 
   
 
 
 
The accompanying notes are an integral part of the unaudited condensed financial statements.
 
1

ALTIMETER GROWTH CORP. 2
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
 
 
  
For the three months ended
 
 
For the three months ended
 
 
  
March 31, 2022
 
 
March 31, 2021
 
Operating costs
   $ 509,197     $ 256,296  
    
 
 
   
 
 
 
Loss from operations
  
 
(509,197
 
 
(256,296
Other income (expense):
                
Interest earned on marketable securities held in Trust Account
     36,728       5,862  
Change in fair value of FPA Asset
     (260,521 )     (1,664,090
    
 
 
   
 
 
 
Net Loss
  
$
(732,990
 
$
(1,914,524
    
 
 
   
 
 
 
Weighted average shares outstanding, Class A ordinary shares
(1)
     46,100,000       40,465,556  
    
 
 
   
 
 
 
Basic and diluted net loss per share, Class A ordinary shares
(1)
  
$
(0.01)
 
 
$
(0.04
    
 
 
   
 
 
 
Weighted average shares outstanding, Class B ordinary shares
(1)
     11,250,000       11,097,222  
    
 
 
   
 
 
 
Basic and diluted net loss per share, Class B ordinary shares
(1)
  
$
(0.01
 
$
(0.04
    
 
 
   
 
 
 
 
(1)
Subsequent to March 31, 2021, the Company adjusted its approach in calculating net loss per share to comply with FASB ASC Topic 260, “Earnings Per Share”. In doing so, the Company adopted a pro-rata approach between its two classes of shares. All share and per-share data have been retroactively restated to reflect this change.
The accompanying notes are an integral part of the unaudited condensed financial statements.
 
2

ALTIMETER GROWTH CORP. 2
CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT
FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND MARCH 31, 2021
(UNAUDITED)
 
 
  
Class A
Ordinary Shares
 
  
Class B
Ordinary Shares
 
  
Additional
Paid-in
Capital
 
  
Accumulated
Deficit
 
 
Total
Shareholders’
Deficit
 
 
  
Shares
 
  
Amount
 
  
Shares
 
  
Amount
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance — January 1, 2022
  
 
1,100,000
 
  
$
110
 
  
 
11,250,000
 
  
$
1,125
 
  
$
  
 
  
$
(15,385,505
 
$
(15,384,270
Net loss
     —          —          —          —          —          (732,990     (732,990
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
Balance — March 31, 2022
  
 
1,100,000
 
  
$
110
 
  
 
11,250,000
 
  
$
1,125
 
  
$
  
 
  
$
(16,118,495
 
$
(16,117,260
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
 
 
 
  
Class A
Ordinary Shares
 
  
Class B
Ordinary Shares
 
  
Additional
Paid-in

Capital
 
 
Accumulated
Deficit
 
 
Total
Shareholders’
Deficit
 
 
  
Shares
 
  
Amount
 
  
Shares
 
  
Amount
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance — January 1, 2021
  
 
  
 
  
$
  
 
  
 
11,250,000
 
  
$
1,125
 
  
$
23,875
 
 
$
(5,000
 
$
20,000
 
Sale of 1,100,000 Private Placement Shares
     1,100,000        110        —          —          10,999,890       —         11,000,000  
Accretion to Class A ordinary shares subject to possible redemption
     —          —          —          —          (11,023,765     (14,281,010     (25,304,775
Net loss
     —          —          —          —          —         (1,914,524     (1,914,524
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
Balance — March 31, 2021
  
 
1,100,000
 
  
$
110
 
  
 
11,250,000
 
  
$
1,125
 
  
$
  
 
 
$
(16,200,534
 
$
(16,199,299
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
   
 
 
   
 
 
 
The accompanying notes are an integral part of the unaudited condensed financial statements.
 
3
ALTIMETER GROWTH CORP. 2
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
 
 
  
For the three months
ended March 31, 2022
 
 
For the three months
ended March 31, 2021
 
Cash flow from Operating Activities:
  
     
 
     
 
 
 
 
 
 
 
 
 
Net loss
   $ (732,990   $ (1,914,524
Adjustments to reconcile net loss to net cash used in operating activities:
                
Interest earned on marketable securities held in Trust Account
     (36,728     (5,862
Changes in fair value of FPA
     260,521       1,664,090  
Changes in operating assets and liabilities:
                
Prepaid expenses
     105,130       (692,333
Accrued Expenses
     24,689       93,926  
    
 
 
   
 
 
 
Net cash used in operating activities
  
 
(379,378
 
 
(854,703
    
 
 
   
 
 
 
Cash Flow from Investing Activities:
                
Investment of cash in Trust Account
              (450,000,000
    
 
 
   
 
 
 
Net cash used in investing activities
    
  
     
(450,000,000
)
 
    
 
 
   
 
 
 
Cash flows from Financing Activities:
                
Proceeds from sale of Units, net of underwriting discounts paid
              441,000,000  
Proceeds from sale of private placement units
              11,000,000  
Repayment of promissory note – related party
              (144,545
Payment of offering costs
              (390,230
    
 
 
   
 
 
 
Net cash provided by financing activities
           
 
451,465,225
 
    
 
 
   
 
 
 
Net change in cash
  
 
(379,378
 
 
610,522
 
Cash – Beginning of period
     398,681           
    
 
 
   
 
 
 
Cash – End of Period
  
$
19,303
 
 
$
610,522
 
    
 
 
   
 
 
 
Non-Cash investing and financing activities:
                
Offering costs paid through promissory note
   $        $ 24,955  
    
 
 
   
 
 
 
Deferred underwriting fee payable
   $ —       $ 15,750,000  
    
 
 
   
 
 
 
The accompanying notes are an integral part of the unaudited condensed financial statements.
 
4

ALTIMETER GROWTH CORP. 2
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
NOTE 1 — ORGANIZATION AND PLAN OF BUSINESS OPERATIONS
Altimeter Growth Corp. 2 (the “Company”) is a blank check company incorporated as a Cayman Islands exempted company on October 14, 2020. The Company was incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (a “Business Combination”).
The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
As of March 31, 2022, the Company had not commenced any operations. All activity for the period from October 14, 2020 (inception) through March 31, 2022 relates to the Company’s formation, the initial public offering (“Initial Public Offering”), which is described below, and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates
non-operating
income in the form of interest income from the proceeds derived from the Initial Public Offering.
The registration statement for the Company’s Initial Public Offering was declared effective on January 6, 2021. On January 11, 2021, the Company consummated the Initial Public Offering of 45,000,000 Class A ordinary shares (the “Public Shares”) at $10.00 per Public Share, which includes the full exercise by the underwriter of its over-allotment option in the amount of 5,000,000 Public Shares at $10.00 per Public Share, generating gross proceeds of $450,000,000 which is described in Note 3.
Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 1,100,000 shares (the “Private Placement Shares”) at a price of $10.00 per Private Placement Share in a private placement to Altimeter Growth Holdings 2 (the “Sponsor”), generating gross proceeds of $11,000,000, which is described in Note 4.
Transaction costs amounted to $25,304,775, consisting of $9,000,000 of underwriting fees, $15,750,000 of deferred underwriting fees and $554,775 of other offering costs.
Following the closing of the Initial Public Offering on January 11, 2021, an amount of $450,000,000 ($10.00
per Public Share) from the net proceeds of the sale of the Public Shares in the Initial Public Offering and the sale of the Private Placement Shares was placed in a trust account (the “Trust Account”), and has been invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of
185 days or less, or in any open-ended investment company that holds itself out as a money market fund investing solely in U.S. Treasuries and meeting certain conditions under Rule
2a-7
of the Investment Company Act, as determined by the Company, until the earliest of: (i) the completion of a Business Combination and (ii) the distribution of the funds in the Trust Account to the Company’s shareholders, as described below.
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Shares, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The stock exchange listing rules require that the Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the assets held in the Trust Account (excluding the amount of any deferred underwriting discount held in the Trust Account and taxes payable on the income earned on the Trust Account). The Company will only complete a Business Combination if the
post-
Business Combination company owns or acquires 50% or more of the issued and outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act of 1940, as amended (the “Investment Company Act”). There is no assurance that the Company will be able to successfully effect a Business Combination.
The Company will provide the holders of the public shares (the “Public Shareholders”) with the opportunity to redeem all or a portion of their public shares upon the completion of the Business Combination, either (i) in connection with a general meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares, equal to the aggregate amount then on deposit in the Trust Account, calculated as of two business days prior to the consummation of the Business Combination (initially anticipated to be $10.00 per Public Share), including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding Public Shares, subject to certain limitations as described in the prospectus. The
per-share
amount to be distributed to the Public Shareholders who properly redeem their shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). The Class A ordinary shares will be recorded at redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.”
 
5

ALTIMETER GROWTH CORP. 2
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
The Company will proceed with a Business Combination only if the Company has net tangible assets of at least $5,000,001 and, if the Company seeks shareholder approval, it receives an ordinary resolution under Cayman Islands law approving a Business Combination, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the Company. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the same information as would be included in a proxy statement with the SEC prior to completing a Business Combination. If the Company seeks shareholder approval in connection with a Business Combination, the Sponsor has agreed to vote its Founder Shares (as defined in Note 5) and any Public Shares purchased during or after the Initial Public Offering in favor of approving a Business Combination. Additionally, each Public Shareholder may elect to redeem their Public Shares, without voting, and if they do vote, irrespective of whether they vote for or against a proposed Business Combination.
Notwithstanding the foregoing, if the Company seeks shareholder approval of the Business Combination and the Company does not conduct redemptions pursuant to the tender offer rules, a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares without the Company’s prior written consent.
The Sponsor has agreed (a) to waive its redemption rights with respect to any Founder Shares, Private Placement Shares and Public Shares held by it in connection with the completion of a Business Combination and (b) not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the Combination Period (as defined below) or (ii) with respect to any other provision relating to shareholders’ rights or
pre-initial
business combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the Trust Account and not previously released to pay taxes, divided by the number of then issued and outstanding Public Shares.
The Company will have until January 11, 2023 (or until April 11, 2023 if the Company has executed a letter of intent, agreement in principle, or definitive agreement for a Business Combination by January 11, 2023, but the Company has not completed a Business Combination by January 11, 2023) to consummate a Business Combination (the “Combination Period”). However, if the Company has not completed a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the Public Shares, at a
per-share
price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned and not previously released to pay taxes, if any (less up to $100,000 of interest to pay dissolution expenses), divided by the number of then issued and outstanding Public Shares, which redemption will completely extinguish the rights of the Public Shareholders as shareholders (including the right to receive further liquidating distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining Public Shareholders and its Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law.
The Sponsor has agreed to waive its rights to liquidating distributions from the Trust Account with respect to the Founder Shares and Private Placement Shares it will receive if the Company fails to complete a Business Combination within the Combination Period. However, if the Sponsor or any of its respective affiliates acquire Public Shares, such Public Shares will be entitled to liquidating distributions from the Trust Account if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to their deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period, and in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available for distribution will be less than the Initial Public Offering price per share ($10.00).
 
6

ALTIMETER GROWTH CORP. 2
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (other than the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account to below the lesser of (1) $10.00 per Public Share and (2) the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share, due to reductions in the value of trust assets, in each case net of the interest that may be withdrawn to pay taxes. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and as to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust Account due to claims of creditors by endeavoring to have all vendors, service providers (other than the Company’s independent registered public accounting firm), prospective target businesses or other entities with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in or to monies held in the Trust Account.
Liquidity, Capital Resources and Going Concern
At March 31, 2022 and December 31, 2021,
the Company
had cash of $19,303 and $398,681, held outside of the Trust Account, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, properties or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $2,000,000 of such loans may be convertible into shares of the post-Business Combination entity at a price of $10.00 per share at the option of the lender. The shares would be identical to the Private Placement Shares.
In connection with the Company’s assessment of going concern considerations in accordance with Financial Accounting Standard Board’s Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” the Company must consummate an initial Business Combination within 24 months (or 27 months, as applicable) from the closing of our Initial Public Offering or during any Extension Period. It is uncertain that the Company will be able to consummate an initial Business Combination within this time. If an initial Business Combination is not consummated within this time, there will be a mandatory liquidation and subsequent dissolution of the Company. Management has determined that the liquidity condition and mandatory liquidation, should an initial Business Combination not occur, and potential subsequent dissolution raises substantial doubt about the Company’s ability to continue as a going concern. No adjustments have been made to the carrying amounts of assets or liabilities should the Company be required to liquidate after January 11, 2023.
 
7

ALTIMETER GROWTH CORP. 2
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
NOTE 2 — SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying financial statements are presented in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form
10-K
for the year ended December 31, 2021, which contains the audited financial statements and notes thereto. The financial information as of December 31, 2021 is derived from the audited financial statements presented in the Company’s Annual Report on form
10-K
for the year ended December 31, 2021. The interim results for the three months ended March 31, 2022, are not necessarily indicative of the results to be expected for the year ending December 31, 2022 or for any future interim periods.
 
8

ALTIMETER GROWTH CORP. 2
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Emerging Growth Company
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to
non-emerging
growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of the condensed financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed financial statements.
Making estimates requires management to exercise significant judgement. Significant estimates included in these financial statements are the valuation of the FPA asset. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Cash and cash equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of March 31, 2022 and December 31, 2021.
Investments Held in Trust Account
At March 31, 2022 and December 31, 2021, the assets held in the Trust Account were held in money market funds, which are invested primarily in U.S. Treasury Securities.
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption, if any, are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, at March 31, 2022 and December 31, 2021, Class A ordinary shares subject to possible redemption are presented as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value, which resulted in charges against additional paid-in capital (to the extent available) and accumulated deficit.
 
 
 
 
 
 
Gross Proceeds
   $ 450,000,000  
Less:
        
Class A ordinary shares issuance costs
   $ (25,304,776
Plus:
        
Accretion of carrying value to redemption value
   $ 25,304,776  
    
 
 
 
Class A ordinary shares subject to possible redemption
  
$
450,000,000
 
    
 
 
 
 
9

ALTIMETER GROWTH CORP. 2
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
FPA Asset
The Company accounts for the Forward Purchase Agreement (“FPA”) as a derivative instrument based on an assessment of the specific terms of the FPA and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the FPA is a freestanding financial instrument pursuant to ASC 480 and meets the definition of a derivative asset or liability pursuant to ASC 480. This assessment, which requires the use of professional judgment, is conducted at the time of execution of the FPA and as of each subsequent quarterly period end date while the FPA is outstanding. Changes in the estimated fair value of the FPA between reporting periods is recognized as a
non-cash
gain or loss on the statement of operations (see Note 9).
Offering Costs
Offering costs consist of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that are directly related to the Initial Public Offering. Offering costs amounting to $25,304,775 were charged to
temporary
shareholders’ equity upon the completion of the Initial Public Offering.
Income Taxes
The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2022 and December 31, 2021, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States.
Net Loss per Common Share
The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” The Company has two classes of shares, which are referred to as Class A ordinary shares and Class B ordinary shares. Losses are shared pro rata between the two classes of shares. Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares outstanding for the period. Diluted net loss per share reflects the potential dilution that could occur if warrants were to be exercised or converted or otherwise resulted in issuance of Ordinary Shares that then shared in the earnings of the entity. As the exercise of the warrants are contingent upon the completion of a business combination they have not been included in the calculation of diluted net loss per share. Accretion associated with the redeemable Class A ordinary shares is excluded from earnings per share as the redemption value approximates fair value.
The following table reflects the calculation of basic and diluted net loss per ordinary share (in dollars, except per share amounts), as stated in footnote 1 to the Condensed Statement of Operations, these amounts for the three months ended March 31, 2021 have been adjusted to conform with the current year presentation:
 
 
  
For the three months ended

March 31, 2022
 
 
For the three months ended

March 31, 2021
 
 
  
Class A
 
 
Class B
 
 
Class A
 
 
Class B
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted net loss per ordinary share
                                
Numerator:
                                
Allocation of net loss
   $ (589,204   $ (143,786   $ (1,502,485   $ (412,039
Denominator:
                                
Basic and diluted weighted average shares outstanding
     46,100,000       11,250,000       40,465,556       11,097,222  
    
 
 
   
 
 
   
 
 
   
 
 
 
Basic and diluted net loss per ordinary share
   $ (0.01   $ (0.01   $ (0.04   $ (0.04
    
 
 
   
 
 
   
 
 
   
 
 
 
 
10

ALTIMETER GROWTH CORP. 2
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such accounts.
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurement,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature, other than the FPA asset.
Recent Accounting Standards
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2020-06,
Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic
815-40)
(“ASU 2020- 06”) to simplify accounting for certain financial instruments. ASU
2020-06
eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU
2020-06
amends the diluted earnings per share guidance, including the requirement to use the
if-converted
method for all convertible instruments. ASU
2020-06
is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of the accounting pronouncement and therefore has not yet adopted as of March 31, 2022.
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s condensed financial statements.
NOTE 3 — INITIAL PUBLIC OFFERING
Pursuant to the Initial Public Offering, the Company sold 45,000,000 Public Shares, which includes a full exercise by the underwriters of their
over-allotment
option in the amount of 5,000,000 Public Shares, at a purchase price of $10.00 per Public Share.
NOTE 4 — PRIVATE PLACEMENT
Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 1,100,000 Private Placement Shares at a price of $10.00 per Private Placement Share, for an aggregate purchase price of $11,000,000, in a private placement. A portion of the proceeds from the Private Placement Shares were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the proceeds from the sale of the Private Placement Shares will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law).
NOTE 5 — RELATED PARTY TRANSACTIONS
Founder Shares
On October 23, 2020, the Sponsor paid $25,000 to cover certain offering and formation costs of the Company in consideration for 2,875,000 Class B ordinary shares (the “Founder Shares”). On December 1, 2020, the Company effected a 2,875,000 share dividend, on December 24, 2020, the Company effected a 4,250,000 share dividend and on January 7, 2021, the Company effected a 1,250,000 share dividend, resulting in an aggregate of 11,250,000 Founder Shares outstanding. All share and
per-share
amounts have been retroactively restated to reflect the share dividends. During December 2020, the Sponsor transferred 75,000 Founder Shares to each of its independent directors, for an aggregate amount of 300,000 Founder Shares transferred.
The Founder Shares included an aggregate of up to 1,250,000 shares subject to forfeiture depending on the extent to which the underwriters’ over- allotment option was not exercised in full, so that the number of Founder Shares would equal, on an
as-converted
basis, approximately 20% of the Company’s issued and outstanding ordinary shares after the Initial Public Offering. As a result of the underwriters’ election to fully exercise their over- allotment option, no Founder Shares are currently subject to forfeiture.
 
11

ALTIMETER GROWTH CORP. 2
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
The Sponsor has agreed, subject to limited exceptions, not to transfer, assign or sell any of the Founder Shares until the earliest of: (A) one year after the completion of a Business Combination and (B) subsequent to a Business Combination, (x) if the closing price of the Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, reorganizations, recapitalizations and the like) for any 20 trading days within any
30-trading
day period commencing at least 120 days after a Business Combination, or (y) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction that results in all of the Public Shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property.
 
12

ALTIMETER GROWTH CORP. 2
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Administrative Support Agreement
The Company entered into an agreement, commencing on January 11, 2021 through the earlier of the Company’s consummation of a Business Combination and its liquidation, to pay an affiliate of the Sponsor $20,000
per month for office space, utilities and secretarial, and administrative support services. For the three months ended March 31, 2022 and the three months ended March 31, 2021, the Company incurred $60,000 in fees for these services. As of March 31, 2022 and December 31, 2021, the Company had
$300,000 and $240,000
of these fees reflected in accrued expenses, respectively.
Promissory Note — Related Party
On October 23, 2020, the Company issued an unsecured promissory note (the “Promissory Note”) to the Sponsor, pursuant to which the Company may borrow up to an aggregate principal amount of $300,000. The Promissory Note is
non-interest
bearing and payable on the earlier of (i) March 31, 2021 or (ii) the completion of the Initial Public Offering. The outstanding balance under the Promissory Note of $144,545 was subsequently repaid on January 15, 2021. As of March 31, 2022, the promissory note expired and the Company is no longer able to borrow funds.
The Sponsor has paid $46,219
directly to vendors on behalf of the Company as of March 31, 2022 and December 31 2021, this amount remains outstanding and is classified as accounts payable — related party on the Company’s condensed balance sheets. 
Related Party Loans
In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $2,000,000 of such Working Capital Loans may be convertible into shares of the post-Business Combination entity at a price of $10.00 per share. The shares would be identical to the Private Placement Shares. As of March 31, 2022 and December 31, 2021, the Company had no outstanding borrowings under the Working Capital Loans.
NOTE 6 — COMMITMENTS AND CONTINGENCIES
Risks and Uncertainties
In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further, the impact of this action and related sanctions on the world economy are not determinable as of the date of these financial statements and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.
Management continues to evaluate the impact of the
COVID-19
global pandemic and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company’s financial position and/or search for a target company, the specific impact is not readily determinable as of the date of the condensed financial statements. The condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.
Registration and Shareholders Rights
Pursuant to a registration and shareholders rights agreement entered into on January 6, 2021, the holders of the Founder Shares and Private Placement Shares and any shares that may be issued upon conversion of Working Capital Loans will be entitled to registration rights pursuant to a registration and shareholder rights agreement to be signed before or on the effective date of the Initial Public Offering. The holders of these securities will be entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the completion of a Business Combination. However, the registration and shareholder rights agreement provides that the Company will not permit any registration statement filed under the Securities Act to become effective until termination of the applicable lockup period. The registration rights agreement does not contain liquidating damages or other cash settlement provisions resulting from delays in registering the Company’s securities. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Pursuant to the forward purchase agreement, the Company will agree that it will use its commercially reasonable efforts to (i) within 30 days after the closing of a Business Combination, file a registration statement with the SEC for a secondary offering of the forward purchase investor’s forward purchase shares and any other Class A ordinary shares acquired by the forward purchase investor, including any acquisitions after the Company completes a Business Combination, (ii) cause such registration statement to be declared effective promptly thereafter, but in no event later than 90 days after the closing of a Business Combination and (iii) maintain the effectiveness of such registration statement and to ensure the registration statement does not contain a material omission or misstatement, including by way of amendment or other update, as required, until the earlier of (A) the date on which a forward purchase investor ceases to hold the securities covered thereby and (B) the date all of the securities covered thereby can be sold publicly without restriction or limitation under Rule 144 under the Securities Act, and without the requirement to be in compliance with Rule 144(c)(1) under the Securities Act, subject to certain conditions and limitations set forth in the forward purchase agreement. The Company will bear the cost of registering these securities.
 
13

ALTIMETER GROWTH CORP. 2
NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS
 
Underwriting Agreement
The underwriters are entitled to a deferred fee of $0.35 per share, or $15,750,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
Forward Purchase Agreement
The Company entered into a forward purchase agreement which will provide for the purchase of a certain number of shares (the “forward purchase shares”), up to 5,000,000 forward purchase shares for $10.00 per share, or an aggregate purchase price of $50,000,000 in a private placement to close concurrently with the closing of a Business Combination. The forward purchase agreement provides that the forward purchase investor may decline to purchase some or all of the forward purchase shares if the Sponsor and the Sponsor’s affiliates collectively own 25% or more of the outstanding shares of the Company when the private placement of the forward purchase shares is initiated.
The obligations under the forward purchase agreement will not depend on whether any Class A ordinary shares are redeemed by the Public Shareholders. The forward purchase shares will be identical to the Class A ordinary shares being sold in the Initial Public Offering, except that they will be subject to certain registration rights. The amount of forward purchase shares sold pursuant to the forward purchase agreement will be determined by the Company at its sole discretion.
NOTE 7 — CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION
The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of future events. The Company is authorized to issue 200,000,000 shares of Class A ordinary shares with a par value of $0.0001 per share. Holders of the Company’s Class A ordinary shares are entitled to one vote for each share. As of March 31, 2022 and December 31, 2021, there were 45,000,000 Class A ordinary shares outstanding which were subject to possible redemption and are classified outside of permanent equity in the condensed balance sheets.
NOTE 8 — SHAREHOLDERS’ DEFICIT
P
r
e
f
e
r
e
n
c
e
Sh
a
r
e
s
— The Company is authorized to issue 1,000,000 preference shares with a par value of $0.0001 per share, with such designations, voting and other rights and preferences as may be determined from time to time by the Company’s board of directors. At March 31, 2022 and December 31, 2021, there were no preference shares issued or outstanding.
Class
 A Ordinary
Shares
— The Company is authorized to issue 200,000,000 Class A ordinary shares, with a par value of $0.0001 per share. Holders of Class A ordinary shares are entitled to one vote for each share. At March 31, 2022 and December 31, 2021, there were 1,100,000 Class A ordinary shares issued and outstanding, excluding 45,000,000
 shares subject to redemption and presented as temporary equity. 
Class
 B Ordinary
Shares
— The Company is authorized to issue 20,000,000 Class B ordinary shares, with a par value of $0.0001 per share. Holders of the Class B ordinary shares are entitled to one vote for each share, there were 11,250,000 Class B ordinary shares issued and outstanding at March 31, 2022 and December 31, 2021.
Holders of Class A ordinary shares and Class B ordinary shares will vote together as a single class on all other matters submitted to a vote of shareholders, except as required by law.
The Class B ordinary shares will automatically convert into Class A ordinary shares at the time of a Business Combination or earlier at the option of the holders thereof at a
ratio
such that the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, on an
as-converted
basis, 20% of the sum of (i) the total number of ordinary shares issued and outstanding upon completion of the Initial Public Offering, plus (ii) the total number of Class A ordinary shares issued or deemed issued or issuable upon conversion or exercise of any equity- linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of a Business Combination (including the forward purchase shares), excluding any forward purchases securities and Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, deemed issued, or to be issued, to any seller in a Business Combination and any Private Placement Shares issued to the Sponsor, its affiliates or any member of the Company’s management team upon conversion of Working Capital Loans. In no event will the Class B ordinary shares convert into Class A ordinary shares at a rate of less than
one-to-one.
 
14
ALTIMETER GROWTH CORP. 2
NOTES TO FINANCIAL STATEMENT
 
NOTE 9 — FAIR VALUE MEASUREMENTS
The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities:
 
 
 
 
Level 1:
  Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.
   
Level 2:
  Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active.
   
Level 3:
  Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability.
At March 31, 2022 and December 31, 2021, assets held in the Trust Account were comprised of $450,064,876 and $450,028,147,
respectively, in money market funds which are invested primarily in U.S. Treasury Securities. During the three months ended March 31, 2022 the Company did
not withdraw any interest income from the Trust Account.
The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at March 31, 2022 and December 31, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Description
  
Level
    
March 31,
2022
    
December 31,
2021
 
Assets:
                          
Investments held in Trust Account – U.S. Treasury Securities Money Market Fund
     1      $ 450,064,876      $ 450,028,147  
FPA Asset
     3      $ 133,829      $ 394,350  
FPA Asset
The asset for the FPA was valued using an adjusted net assets method, which is considered to be a Level 3 fair value measurement. Under the adjusted net assets method utilized, the aggregate commitment of $50 million pursuant to the FPA is discounted to present value and compared to the fair value of the ordinary shares to be issued pursuant to the FPA. The fair value of the ordinary shares to be issued under the FPA is based on the public trading price of the Shares issued in the Company’s Initial Public Offering. The excess (liability) or deficit (asset) of the fair value of the ordinary shares to be issued compared to the $50 
million fixed commitment is then reduced to account for the probability of consummation of the Business Combination. The primary unobservable input utilized in determining the fair value of the FPA is the probability of consummation of the Business Combination. As of March 31, 2022 and December 31, 2021, the probability assigned to the consummation of the Business Combination was 33.3% and 66.7%, respectively, which was determined based on observed success rates of business combinations for special purpose acquisition companies. 
The key inputs into the valuation analysis for the Forward Purchase Agreement were as follows at March 31, 2022 and December 31, 2021:
 
 
 
 
 
 
 
 
 
 
Input
  
March 31,
2022
   
December 31,
2021
 
Risk-free interest rate
     1.3
%
 
    0.3
Years to expected initial business combination date
     0.75       0.75  
Conditional probability of Securities Issued
     33.3     66.7
Fair value of security at valuation date
   $ (0.08   $ (0.12
 
15

ALTIMETER GROWTH CORP. 2
NOTES TO FINANCIAL STATEMENT
 
The following table presents a summary of the changes in the fair value of the FPA asset, a Level 3 asset, measured on a recurring basis.
 
 
  
FPA (Asset)

Liability
 
Fair value, January 11, 2021
   $  
Recognized loss on change in fair value
     1,664,090  
    
 
 
 
Fair value, March 31, 2021
   $ 1,664,090  
    
 
 
 
 
 
 
 
 
Fair value, December 31, 2021
   $ (394,350
Recognized gain on change in fair value
     260,521  
    
 
 
 
Fair value, March 31, 2022
   $ (133,829
    
 
 
 
NOTE 10 — SUBSEQUENT EVENTS
The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the condensed financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the condensed financial statements.
 
ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Altimeter Growth Corp. 2. References to our “management” or our “management team” refer to our officers and directors, references to the “Sponsor” refer to Altimeter Growth Holdings 2. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are
forward-looking
statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of the Company’s Annual Report on Form
10-K
for the year ending December 31, 2021 filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 25, 2022. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated on October 14, 2020 as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). We have not selected any business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. We intend to effectuate our initial business combination using cash from the proceeds of our Initial Public Offering and the sale of our shares, debt or a combination of cash, equity and debt.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
 
16

ALTIMETER GROWTH CORP. 2
NOTES TO FINANCIAL STATEMENT
 
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from inception to March 31, 2022, were organizational activities, those necessary to prepare for the Initial Public Offering, described below, and, after the Initial Public Offering, identifying a target company for a Business Combination. We do not expect to generate any operating revenues until after the completion of our Business Combination. We may generate
non-operating
income in the form of interest income on marketable securities held in the Trust Account. We incur expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing a Business Combination.
For the three months ended March 31, 2022, we had a net loss of $732,990, which consisted of formation and operating expenses of $509,197 offset by a loss on the value of the FPA asset of $260,521 and interest earned on marketable securities held in the trust account of $36,728.
For the three months ended March 31, 2021, we had net loss of $1,914,524, which consisted of a loss on the value of the FPA of $1,664,090 and formation and operating expenses of $256,296, offset by $5,862 of interest earned on marketable securities held in the trust account.
Liquidity, Capital Resources and Going Concern
Until the consummation of the Initial Public Offering, our only source of liquidity was an initial purchase of Class B ordinary shares by our Sponsor and advances from our Sponsor.
On January 11, 2021, we consummated our Initial Public Offering of 45,000,000 shares, which included the full exercise by the underwriters of the
over-allotment
option to purchase an additional 5,000,000 shares, at $10.00 per share, generating gross proceeds of $450,000,000 (the “Initial Public Offering”). Simultaneously with the closing of the Initial Public Offering, we consummated the sale of an aggregate of 1,100,000 Private Placement Shares to our sponsor at a price of $10.00 per share, generating gross proceeds of $11,000,000.
Following the Initial Public Offering, the full exercise of the over-allotment option, and the sale of the Private Placement Shares, a total of $450,000,000 was placed in the Trust Account, and we had $1,995,000 of cash held outside of the Trust Account, after payment of costs related to the Initial Public Offering, and available for working capital purposes. We incurred $25,304,775 in transaction costs, including $9,000,000 of underwriting fees, $15,750,000 of deferred underwriting fees and $554,775 of other offering costs.
For the three months ended March 31, 2022, net cash used in operating activities was $379,378. The net loss of $732,990 was offset by the interest earned on marketable securities held in trust of $36,728 and changes in value of the FPA asset of $260,521 and in operating assets and liabilities used $129,819 of cash from operating activities.
For the three months ended March 31, 2021, net cash used in operating activities was $854,703. The net loss of $1,914,524 was offset by the change in value of the FPA asset of $1,664,090 and interest earned on marketable securities held in trust of $5,862 and changes in operating assets and liabilities used $598,407 of cash from operating activities.
At March 31, 2022 and December 31, 2021, we had cash held in the Trust Account of $450,064,876 and $450,028,147, respectively. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (less taxes payable (if applicable) and deferred underwriting commissions) and the proceeds from the sale of the forward purchase shares to complete our Business Combination. To the extent that our shares or debt is used, in whole or in part, as consideration to complete our Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the post-Business Combination entity, make other acquisitions and pursue our growth strategies.
At March 31, 2022 and December 31, 2021, we had cash of $19,303 and $398,681, held outside of the Trust Account, respectively. We intend to use the funds held outside the Trust Account primarily to identify and evaluate target businesses, perform business due diligence on prospective target businesses, travel to and from the offices, properties or similar locations of prospective target businesses or their representatives or owners, review corporate documents and material agreements of prospective target businesses, and structure, negotiate and complete a Business Combination.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts but no proceeds from our Trust Account would be used for such repayment. Up to $2,000,000 of such loans may be convertible into shares of the post-Business Combination entity at a price of $10.00 per share at the option of the lender.
 
17

ALTIMETER GROWTH CORP. 2
NOTES TO FINANCIAL STATEMENT
 
We do not believe we will need to raise additional funds in order to meet the expenditures required for operating our business. However, if our estimate of the costs of identifying a target business, undertaking
in-depth
due diligence and negotiating and consummating a Business Combination are less than the actual amount necessary to do so, we may have insufficient funds available to operate our business prior to our Business Combination. Moreover, we may need to obtain additional financing either to complete our Business Combination or because we become obligated to redeem a significant number of our public shares upon consummation of our Business Combination, in which case we may issue additional securities or incur debt in connection with such Business Combination. Subject to compliance with applicable securities laws, we would only complete such financing simultaneously with the completion of our Business Combination. If we are unable to complete our Business Combination because we do not have sufficient funds available to us, we will be forced to cease operations and liquidate the Trust Account. In addition, following our Business Combination, if cash on hand is insufficient, we may need to obtain additional financing in order to meet our obligations.
Off-Balance
Sheet Financing Arrangements
We have no obligations, assets or liabilities, which would be considered
off-balance
sheet arrangements as of March 31, 2022 and December 31, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating
off-balance
sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
Contractual Obligations
We do not have any
long-term
debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay affiliate of the Sponsor a monthly fee of $20,000 for office space, utilities and secretarial, and administrative and support services. We began incurring these fees on January 11, 2021 and will continue to incur these fees monthly until the earlier of the completion of the Business Combination and our liquidation.
The underwriters are entitled to a deferred fee of $0.35 per share, or $15,750,000 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.
We entered into a forward purchase agreement which provides for the purchase of a certain number of shares (the “forward purchase shares”), up to 5,000,000 forward purchase shares for $10.00 per share, or an aggregate purchase price of $50,000,000 in a private placement to close concurrently with the closing of a Business Combination.
Critical Accounting Estimates
This management’s discussion and analysis of our financial condition and results of operations is based on our financial statements, which have been prepared in accordance with United States Generally Accepted Accounting Polices (“GAAP”). The preparation of our financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our financial statements. On an ongoing basis, we evaluate our estimates and judgments, including those related to fair value of financial instruments and accrued expenses. We base our estimates on historical experience, known trends and events and various other factors that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions. The Company has identified the following as its critical accounting policies:
 
18

ALTIMETER GROWTH CORP. 2
NOTES TO FINANCIAL STATEMENT
 
FPA
The Company accounts for the Forward Purchase Agreement (“FPA”) as a derivative instrument based on an assessment of the specific terms of the FPA and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). This assessment, which requires the use of professional judgment, is conducted at the time of execution of the FPA and as of each subsequent quarterly period end date while the FPA is outstanding. Changes in the estimated fair value of the FPA between reporting periods is recognized as a
non-cash
gain or loss on the statement of operations. The inputs used by the Company to value its FPA require estimation by the Company. To demonstrate the sensitivity to the most judgmental areas of this estimate, a 1% increase in the present value of the security input would increase the Company’s FPA asset by approximately $350,000.
Recent Accounting Standards
In August 2020, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
2020-06,
Debt — Debt with Conversion and Other Options (Subtopic
470-20)
and Derivatives and Hedging — Contracts in Entity’s Own Equity (Subtopic
815-40)
(“ASU 2020- 06”) to simplify accounting for certain financial instruments. ASU
2020-06
eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU
2020-06
amends the diluted earnings per share guidance, including the requirement to use the
if-converted
method for all convertible instruments. ASU
2020-06
is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the impact of the accounting pronouncement and therefore has not yet adopted as of March 31, 2022. Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our unaudited condensed financial statements.
 
ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are a smaller reporting company as defined by Rule
12b-2
of the Exchange Act and are not required to provide the information otherwise required under this item.
 
ITEM 4.
CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of March 31, 2022, as defined in Rules 13a-15(e) and
15d-15(e)
under the Exchange Act. Based on their evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures (as defined in Rules 13a-15 (e) and 15d-15 (e) under the Exchange Act) were effective.
 
19

ALTIMETER GROWTH CORP. 2
NOTES TO FINANCIAL STATEMENT
 
Changes in Internal Control Over Financial Reporting
During the fiscal quarter ended March 31, 2022, there has been no change in our internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. The material weakness discussed below was remediated during the quarter ended March 31, 2022.
Remediation of a Material Weakness in Internal Control over Financial Reporting
We recognize the importance of the control environment as it sets the overall tone for the Company and is the foundation for all other components of internal control. Consequently, we designed and implemented remediation measures to address the material weakness previously identified in our Annual Report on Form
10-K
for the fiscal year ended December 31, 2021 and enhanced our internal control over financial reporting. In light of the material weakness, we enhanced our processes to identify and appropriately apply applicable accounting requirements in order to better evaluate and understand the nuances of the complex accounting standards that apply to our condensed consolidated financial statements, including providing enhanced access to accounting literature, research materials and documents as well as increased communication among our personnel and third-party professionals with whom we consult regarding complex accounting applications. The foregoing actions, which we believe remediated the material weakness in internal control over financial reporting, were completed during the fiscal quarter ended March 31, 2022.
 
20

PART II - OTHER INFORMATION
 
ITEM 1.
LEGAL PROCEEDINGS.
None.
 
ITEM 1A.
RISK FACTORS.
Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in our Annual Report on Form 10-K for the year ended December 31, 2021 filed with the SEC on March 25, 2022 (the “Annual Report”). Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of this Quarterly Report, there have been no material changes to the risk factors disclosed in our Annual Report filed with the SEC.
 
ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS FROM REGISTERED SECURITIES.
On January 11, 2021, we consummated our Initial Public Offering of 45,000,000 shares, which included the full exercise by the underwriters of the over-allotment option to purchase an additional 5,000,000 shares, at $10.00 per share, generating gross proceeds of $450,000,000. Citigroup Global Markets Inc., Goldman Sachs & Co. LLC and Morgan Stanley & Co. LLC acted as book-running managers of the offering. The securities sold in the offering were registered under the Securities Act on a registration statement on Form S-1 (No. 333- 251431). The SEC declared the registration statement effective on January 6, 2021.
Simultaneously with the consummation of the Initial Public Offering we consummated a private placement of 1,100,000 Private Placement Shares to our sponsor at a price of $10.00 per share, generating total proceeds of $11,000,000. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
The Private Placement Shares are identical to the Class A ordinary shares sold in the Initial Public Offering, subject to certain limited exceptions.
Of the gross proceeds received from the Initial Public Offering and the Private Placement Shares, $450,000,000 was placed in the Trust Account.
We paid a total of $9,000,000 in upfront underwriting discounts and commissions and $554,775 for other offering costs related to the Initial Public Offering. In addition, the underwriters agreed to defer $15,750,000 in underwriting discounts and commissions.
For a description of the use of the proceeds generated in our Initial Public Offering, see Part I, Item 2 of this Quarterly Report.
 
ITEM 3.
DEFAULTS UPON SENIOR SECURITIES.
None.
 
ITEM 4.
MINE SAFETY DISCLOSURES.
Not applicable.
 
ITEM 5.
OTHER INFORMATION.
None.
 
21

ITEM 6.
EXHIBITS.
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form
10-Q.
 
No.
  
Description of Exhibit
   
31.1*    Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a—14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   
31.2*    Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
   
32.1**    Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes— Oxley Act of 2002
   
32.2**    Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes— Oxley Act of 2002
   
101.INS*    Inline XBRL Instance Document
   
101.CAL*    Inline XBRL Taxonomy Extension Calculation Linkbase Document
   
101.SCH*    Inline XBRL Taxonomy Extension Schema Document
   
101.DEF*    Inline XBRL Taxonomy Extension Definition Linkbase Document
   
101.LAB*    Inline XBRL Taxonomy Extension Labels Linkbase Document
   
101.PRE*    Inline XBRL Taxonomy Extension Presentation Linkbase Document
   
104    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
 
*
Filed herewith.
**
Furnished.
 
22

SIGNATURES
Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
        ALTIMETER GROWTH CORP. 2
       
Date:  May 16, 2022          
/s/ Brad Gerstner
        Name: Title:  
Brad Gerstner
Chief Executive Officer, President and Chairman
(Principal Executive Officer)
       
Date:  May 16, 2022          
/s/ Hab Siam
        Name: Title:  
Hab Siam
General Counsel
(Principal Financial and Principal Accounting Officer)
 
23